by PEPID Newsroom | Mar 14, 2019 | Alerts
The Food and Drug Administration (FDA) has allowed marketing of ClearMate to treat patients suffering from carbon monoxide poisoning in emergency rooms. Malvina Eydelman, M.D., director of the Division of Ophthalmic, and Ear, Nose and Throat Devices in the FDA’s...
by PEPID Newsroom | Mar 14, 2019 | Alerts
As of March 12, 2019 the U.S. FDA approved a new generic of Diovan (valsartan) for high blood pressure and heart failure to relieve the shortage from multiple recalls of generic valsartan products from several manufacturers. The approval of the new generic of Diovan...
by PEPID Newsroom | Mar 6, 2019 | Alerts
Measles, also known as rubeola or “first disease”, is a highly contagious viral infection caused by paramyxovirus, causing a prodrome of fever, cough, coryza, and conjunctivitis followed by eruption of maculopapular rash. The CDC states 2 main reasons for the increase...
by PEPID Newsroom | Feb 27, 2019 | Alerts
CDC published a report today that provides the most recent data on HIV trends in America from 2010 to 2016. The results show a stagnation in the decline of HIV infections, with numbers of HIV Infections leveling off at about 39,000. When taking a deeper dive into the...
by PEPID Newsroom | Feb 13, 2019 | Emergency Medicine, Nursing, Pharmacy, Primary Care
Founder and CEO, Mark Rosenbloom, MD, MBA joins PEPID Pulse’s Implementing Precision Medicine live broadcast series at HIMSS 2019. Dr. Rosenbloom’s talk, “Implementing Precision Medicine in the Clinical Setting: Challenges and Rewards” expounds on: Pharmacogenomics’...
